The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)

BACKGROUND: Triple Negative Breast Cancers (TNBCs) lack the appropriate targets for currently used breast cancer therapies, conferring an aggressive phenotype, more frequent relapse and poorer survival rates. The biological heterogeneity of TNBC complicates the clinical treatment further. We have ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Narrandes, Shavira, Huang, Shujun, Murphy, Leigh, Xu, Wayne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753474/
https://www.ncbi.nlm.nih.gov/pubmed/29301506
http://dx.doi.org/10.1186/s12885-017-3939-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753474/
https://www.ncbi.nlm.nih.gov/pubmed/29301506
http://dx.doi.org/10.1186/s12885-017-3939-4

Ejemplares similares